Allergan, Inc.

Lake Bluff, IL

UEI
HC62HHL8JKY3
CAGE
1V0P7
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
1 Waukegan Rd, Lake Bluff, IL 60044, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $75,215
FY2024 $105,091
FY2023 $65,312

Contract awards

Award Agency Obligated Awarded
Breast implants 36C24225P0839 Veterans Integrated Service Network 2 (VHA) $2,492
Implant 36C24225P0588 Veterans Integrated Service Network 2 (VHA) $35,788
Implants 36C24225P0330 Veterans Integrated Service Network 2 (VHA) $0
Implants 36C24225P0293 Veterans Integrated Service Network 2 (VHA) $36,934
Breast implants 36C24224P1775 Veterans Integrated Service Network 2 (VHA) $14,187

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Allergan, Inc., a subsidiary of AbbVie Inc., is a for-profit medical device manufacturer specializing in advanced healthcare technologies and innovative medical products. Registered in the System for Award Management (SAM) since November 6, 2001, the company focuses on producing sophisticated medical devices, with a particular emphasis on surgical and reconstructive medical components. The company's core business involves developing and manufacturing medical implants, prosthetic devices, and specialized surgical supplies, primarily targeting federal healthcare agencies such as the Department of Veterans Affairs (VA) and the Defense Health Agency.

Allergan, Inc. has consistently provided federal agencies with a range of medical products, predominantly breast implants, tissue expanders, allografts, and surgical reconstruction components. The majority of its federal contract awards have been purchase orders and blanket purchase agreements (BPAs) with ceiling values ranging from a few thousand to $250,000, primarily issued by Veterans Integrated Service Networks (VISN) and the Defense Health Agency. These contracts have consistently been awarded without specific set-aside designations, indicating open competition. The company's federal contract portfolio demonstrates a strong focus on supporting veteran healthcare, with numerous contracts specifically addressing breast reconstruction, surgical implants, and prosthetic devices. Notably, Allergan has maintained a steady stream of federal contract awards across multiple agency networks, suggesting a reliable and trusted supplier of critical medical technologies for federal healthcare systems.

Quick answers

Is Allergan, Inc. registered in SAM.gov?

Yes. Allergan, Inc.'s SAM.gov registration is active through June 8, 2027.

How much has Allergan, Inc. received in federal contracts?

Federal contracts obligated $75,215 to Allergan, Inc. in fiscal year 2025 and $245,618 in fiscal years 2023 through 2027.

What is Allergan, Inc.'s most recent federal award?

Allergan, Inc.'s most recent federal contract award is Breast implants (36C24225P0839), from Veterans Integrated Service Network 2 (VHA), on April 3, 2025.

On GovTribe

See Allergan, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors